News|Articles|July 30, 2024
Hydrophobic Interaction Chromatography: A Platform for Characterizing Antibody-Drug Conjugates
Author(s)Tosoh Bioscience
Characterizing the ratio of tumor-killing payload to cancer-binding antibody (DAR) is a critical quality attribute that helps determine the potential potency of a given antibody-drug conjugate (ADC) candidate. The TSKgel® HIC-ADC Butyl column, developed by Tosoh Bioscience, enables improved HIC-based separations for quantifying the DAR of ADCs.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Related Content
Trending on LCGC International
1
Voices from the Analytical Front Line: Thomas Letzel on Chromatography in 2026
2
Voices from the Analytical Front Line: Bingchuan Wei on Chromatography in 2026
3
GC–MS Profiling Reveals Ethyl Lactate’s Regulatory Role in Baijiu Aroma Development During Aging
4
Chromatographic Evaluation of CO₂-Controlled Fermentation Effects on the Sensory and Chemical Quality of Dry-Processed Coffees
5